PRA International: Participating Sponsor for Exploratory Clinical Development World... ( RALEIGH N.C. May 12 /- PRA Internatio...)

PRA International: Participating Sponsor for Exploratory Clinical Development World in London

Date:5/12/2009

RALEIGH, N.C., May 12 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces it is participating as a sponsor for Exploratory Clinical Development World (ECDW), 13-14 May 2009, in London, UK. ECDW is considered to be Europe's largest and most highly regarded early development congress. Experts from PRA's Early Development Services (EDS) group will be available to discuss PRA's capabilities at ECDW. Please contact Martin Schuiling (schuilingmartin@praintl.com) to schedule a meeting and learn more.

With harmonized clinical and laboratory facilities, 228 beds in Europe and the US and an innovative Early Development model that brings the center to the patients in Central/Eastern Europe, PRA's EDS group provides comprehensive services for Phase I and Phase IIa studies. PRA's integrated data support, in-house pharmacy and expedited regulatory approval timelines in The Netherlands enable PRA to reduce timelines for sponsors.

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONA<
'/>"/>

SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
2. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
3. HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
4. Concentric Medical to Sponsor Randomized Trial
5. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
6. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
7. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
9. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
10. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
11. Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)

Post Your Comments:

(Date:12/4/2009)... , WINSTON-SALEM, N.C., Dec. 4 /PRNewswire-...ral grant will support researchers at the Universi...aborators at Wake Forest University as they study ...es over time and how to address the problem. This ...associated with increased risk for cardiovascular ...

(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswir...sures volume changes in the size of suspicious nod...le out non-cancerous ones with almost perfect accu...ith fewer, less expensive and less invasive tests..../20081016/LCALOGO ) ,, The new diagnostic guide...

(Date:12/4/2009)... , INDIANAPOLIS, Dec. 4 /PRNewswire-Firs...(FDA) today approved Zyprexa® (olanzapine) in...izophrenia and manic or mixed episodes associated ...years old. ,, The updated Zyprexa label states...e increased potential for weight gain and hyperlip...

Breaking Medicine Technology:NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2 NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3 European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7 Nostrils alternate to process competing odors 9636 1 Nostrils alternate to process competing odors 9636 2 ESCO Announces Major Contract Award for Its Thermoforming Business 54966 1 ESCO Announces Major Contract Award for Its Thermoforming Business 54966 2 Nostrils Compete to Relay Key Fragrance 54963 1 Nostrils Compete to Relay Key Fragrance 54963 2

[0] NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood [0] European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis [0] FDA Approves Lilly's Zyprexa for Two Adolescent Indications

...in Fight Against MRSA, WASHINGTON, Oct. 18 Build... a worrisome staph infection by 50 percent,the Dep...eening,requirements now in place in all of its 153...tment to hospital hygiene and,flagging affected pa...tor,all incoming patients on key units with nasal ...

...icena Group,Inc. (OTC Bulletin Board: AVGO), a lat...l nervous system therapeutics for neurodegenerativ...he Company,s Amyotrophic,Lateral Sclerosis (ALS) d...h International Symposium on ALS/MND which will be...e poster presentation by Allitia DiBernardo,M.D. o...

Other Medicine Technology:VA National Campaign Takes Aim at Resistant Staph Infections 2 Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND 2 Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND 3

VA National Campaign Takes Aim at Resistant Staph Infections Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND

(Date:12/5/2009)... CAPE TOWN, South Africa, December 5 /PRNewswire/...sha in the outskirts of Cape Town opened its doors... Blatter was joined by,Western Cape Premier Helen ...uth Africa (OC) CEO Danny Jordaan, South African F...and Executive Mayor of the City of Cape Town,Dan P...

(Date:12/5/2009)...st Babies, This Type of Blood Cancer Is Most Chall.... 5 Pediatric oncologis...genes, that fuse with another gene to drive an oft...rately defining specific partner genes, researcher...it from particular treatments. ,, Oncologists ...

(Date:12/5/2009)..., Dec. 5 Leukemia and m...deadly blood cancers. Research presented today at ... Hematology introduces potential new treatment opt...suffering from acute promyelocytic leukemia, chron...ukemia, and myelofibrosis that are based on a bett...

(Date:12/5/2009)...gers, experts advise , , SATURDAY, Dec. ...ople with allergies and asthma can have bad reacti... special steps to prevent sneezing and wheezing, a...a and Immunology (ACAAI). , Those who are aller... artificial plants, but both live and artificial t...

(Date:12/5/2009)...ing,s wrong with being single, myth , , ... single people who pass their 40th birthday withou...at never-married adults have more health woes than...ng with those who go it alone anyway? , Not so ...asures shows that never-married people aged 40 and...

[0] Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha [0] New Gene Findings Will Help Guide Treatment in Infant Leukemia [0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] Keep Asthma, Allergies at Bay for the Holidays [0] Never Married, Over 40, Well-Adjusted

...BOTT PARK, Ill., Jan. 29 Abbott will,present at t...ogy and,Medical Device Conference on Tuesday, Feb....nt, finance and chief financial officer, will make...or Relations Web site at http://www.abbottinvesto...

...itiative Provides a New Way to Shop for Baby Produ...and Easy-To-Follow Links to Major Retailers as ...rgia, January 29 BabySupply.Info, has,launched to...g comparison engine for baby products and more., ...

...ndings identify proteins that determine nature of ...an. 29 (HealthDay News) -- U.S. researchers have m...ected in complex signaling networks that control n...injuries, a new study says. , The University of Ca...

...NVER, Jan. 29 HealthAware, a leading supplier of,...nced today the launch of,WeightAware, the newest d...tAware is designed to benefit people struggling wi...f HealthAware,s industry-leading,Cardiovascular Pr...

... The Approval Creates New Growth Opportunities for...ign Related to the SFDA Drug Approval ...China, Jan. 29 /Xinhua-PRNewswire-FirstCall/ --,Ch...roducts in China, announced today that it has rece...

...W YORK, January 29 , - Elsevier,s Beta Medical Wi...Collaborate and Update Established Medical Textboo...r of science and health,information, announced tod...edical information online. The,site, which is open...

Other Medicine News:Health News:BabySupply.Info Announces Launch of Website for New Parents 2 Health News:Researchers Map Paths Governing Neuron Function 2 Health News:HealthAware Introduces Its WeightAware Cardiovascular Disease Module 2 Health News:China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection 2 Health News:China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection 3 Health News:Elsevier's "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights 2 Health News:Elsevier's "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights 3

Abbott to Present at Merrill Lynch Healthcare Conference BabySupply.Info Announces Launch of Website for New Parents Researchers Map Paths Governing Neuron Function HealthAware Introduces Its WeightAware Cardiovascular Disease Module China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection Elsevier's "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights

Multi Frequency Prostate Biopsy Transducer UST-675P

Multi Frequency Small Parts Linear Transducer UST-5712

Multi-frequency Steered Linear Transducer

Multi Frequency Convex Abdominal Transducer UST-9114-3.5

Medicine Products:

Multi Frequency Prostate Biopsy Transducer UST-675P Multi Frequency Small Parts Linear Transducer UST-5712 Multi-frequency Steered Linear Transducer Multi Frequency Convex Abdominal Transducer UST-9114-3.5

PRA International: Participating Sponsor for Exploratory Clinical Development World...( RALEIGH N.C. May 12 /- PRA Internatio...),Health